These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 28933520)
1. Anticoagulation and antiplatelet therapy in patients with peripheral arterial disease of the femoropopliteal arteries. Vos CG; Vahl AC J Cardiovasc Surg (Torino); 2018 Apr; 59(2):164-171. PubMed ID: 28933520 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease. Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407 [TBL] [Abstract][Full Text] [Related]
3. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass. Rychlik IJ; Davey P; Murphy J; O'Donnell ME J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic treatment in peripheral artery disease. Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765 [TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. Lumsden AB; Morrissey NJ; J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929 [TBL] [Abstract][Full Text] [Related]
6. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass. Assadian A; Eckstein HH; J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193 [TBL] [Abstract][Full Text] [Related]
7. A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention. Tangelder MJ; Nwachuku CE; Jaff M; Baumgartner I; Duggal A; Adams G; Ansel G; Grosso M; Mercuri M; Shi M; Minar E; Moll FL J Endovasc Ther; 2015 Apr; 22(2):261-8. PubMed ID: 25809373 [TBL] [Abstract][Full Text] [Related]
8. Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients. Mackman N; Spronk HMH; Stouffer GA; Ten Cate H Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):726-732. PubMed ID: 29449336 [No Abstract] [Full Text] [Related]
9. Antithrombotic Therapy in Lower Extremity Artery Disease. Vrsalovic M; Aboyans V Curr Vasc Pharmacol; 2020; 18(3):215-222. PubMed ID: 30727898 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of PTFE trilaminate graft versus venous graft and composite graft for below-the-knee revascularization. Mazzaccaro D; De Febis E; Settembrini AM; Tassinari L; Carmo M; Settembrini PG J Cardiovasc Surg (Torino); 2014 Oct; 55(5):685-91. PubMed ID: 25008059 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients. Monaco M; Di Tommaso L; Pinna GB; Lillo S; Schiavone V; Stassano P J Vasc Surg; 2012 Jul; 56(1):96-105. PubMed ID: 22551909 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet and anticoagulation therapy after revascularization for lower extremity artery disease: a national survey and literature overview. Ipema J; Brand AR; DE Borst GJ; DE Vries JP; ÜnlÜ Ç J Cardiovasc Surg (Torino); 2021 Feb; 62(1):59-70. PubMed ID: 33112125 [TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. McQuade K; Gable D; Hohman S; Pearl G; Theune B J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055 [TBL] [Abstract][Full Text] [Related]
16. Medical and lifestyle management of peripheral arterial disease. Parvar SL; Fitridge R; Dawson J; Nicholls SJ J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849 [TBL] [Abstract][Full Text] [Related]
17. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402 [TBL] [Abstract][Full Text] [Related]
18. Comparison of precuffed expanded polytetrafluorothylene and heparin-bonded polytetrafluorothylene graft in crural bypass. Bellosta R; Natalini G; Luzzani L; Carugati C; Sarcina A Ann Vasc Surg; 2013 Feb; 27(2):218-24. PubMed ID: 23092735 [TBL] [Abstract][Full Text] [Related]
19. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial. Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876 [TBL] [Abstract][Full Text] [Related]
20. Antithrombotic Therapy for Peripheral Revascularisation. De Carlo M; Angelillis M; Liga R Curr Vasc Pharmacol; 2020; 18(3):223-236. PubMed ID: 30727899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]